Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-160X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology ; volume:36 ; number:5 ; day:27 ; month:2 ; year:2016 ; pages:613-625 ; date:5.2016
Rheumatology international ; 36, Heft 5 (27.2.2016), 613-625, 5.2016
- Urheber
-
Mysler, Eduardo
- Beteiligte Personen und Organisationen
-
Pineda, Carlos
Horiuchi, Takahiko
Singh, Ena
Mahgoub, Ehab
Coindreau, Javier
Jacobs, Ira
SpringerLink (Online service)
- DOI
-
10.1007/s00296-016-3444-0
- URN
-
urn:nbn:de:1111-201608038905
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mysler, Eduardo
- Pineda, Carlos
- Horiuchi, Takahiko
- Singh, Ena
- Mahgoub, Ehab
- Coindreau, Javier
- Jacobs, Ira
- SpringerLink (Online service)
Ähnliche Objekte (12)
Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry
What is the future of targeted therapy in rheumatology: biologics or small molecules?
Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score–Matched Analysis from the Korean College of Rheumatology Biologics Registry
Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!
Rheumatology
The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries
Imaging in rheumatology: reconciling radiology and rheumatology
Biologics in therapy
BMC Rheumatology
Modern rheumatology
Pediatric rheumatology
Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry
What is the future of targeted therapy in rheumatology: biologics or small molecules?
Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score–Matched Analysis from the Korean College of Rheumatology Biologics Registry
Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!
Rheumatology
The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries
Imaging in rheumatology: reconciling radiology and rheumatology
Biologics in therapy
BMC Rheumatology
Modern rheumatology
Pediatric rheumatology
Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry
What is the future of targeted therapy in rheumatology: biologics or small molecules?
Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score–Matched Analysis from the Korean College of Rheumatology Biologics Registry
Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!
Rheumatology
The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries
Imaging in rheumatology: reconciling radiology and rheumatology
Biologics in therapy
BMC Rheumatology
Modern rheumatology